(Q44563618)

4 December 2017

title

Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3. (English)

1 reference

4 December 2017

Han-Cheng Zhang

1

1 reference

4 December 2017

Kimberly B White

2

1 reference

4 December 2017

Hong Ye

3

1 reference

4 December 2017

David F McComsey

4

1 reference

4 December 2017

Claudia K Derian

5

1 reference

4 December 2017

Michael F Addo

6

1 reference

4 December 2017

Patricia Andrade-Gordon

7

1 reference

4 December 2017

Annette J Eckardt

8

1 reference

4 December 2017

Bruce R Conway

9

1 reference

4 December 2017

Lori Westover

10

1 reference

4 December 2017

Jun Z Xu

11

1 reference

4 December 2017

Richard Look

12

1 reference

4 December 2017

Keith T Demarest

13

1 reference

4 December 2017

Stuart Emanuel

14

1 reference

4 December 2017

Bruce E Maryanoff

15

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

4 December 2017

published in

1 reference

4 December 2017

volume

13

1 reference

4 December 2017

issue

18

1 reference

4 December 2017

page(s)

3049-3053

1 reference

ATP site-directed competitive and irreversible inhibitors of protein kinases

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Protein kinases as therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

The protein kinase complement of the human genome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Protein kinase C and the development of diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Regulation of angiogenesis by glycogen synthase kinase-3beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Current therapies and emerging targets for the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Glycogen synthase kinase 3: an emerging therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Protein kinase C inhibitors as novel anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900644-9

7 January 2021

10.1016/S0960-894X(03)00644-9

Identifiers

DOI

1 reference

4 December 2017

1 reference